Maarten Ooms

Research output

Research output per year 2019 2021 2022 2025

• 18 In-proceedings paper
• 17 Article
• 2 Literature review
• 1 ER - External report
• 2 More
  • 1 Chapter
  • 1 Special issue

Research output per year

Research output per year

Search results

• 2025

  Cysteine-selective [¹⁸⁸Re]Re(v) radiolabelling of a Nanobody® for targeted radionuclide therapy using a “chelate-then-click” approach

  Melis, D. R., Segers, C., Wellens, J., Van de Voorde, M., Blacque, O., Ooms, M., Gasser, G. & Opsomer, T., 26 Feb 2025, In: Chemical Science. p. 10

  Research output › peer-review

  Open Access

• Mitochondria-tropic radioconjugates to enhance the therapeutic potential of terbium-161

  Santos, J. F., Laere, C. V., Silva, C. D., Cassells, I., Fernandes, C., Raposinho, P., Belchior, A., Pinto, C. I. G., Mendes, F., Cawthorne, C., Ooms, M., Voorde, M. V. D., Cleeren, F. & Paulo, A., Dec 2025, In: EJNMMI Radiopharmacy and Chemistry. 10, 1, 15 p., 18.

  Research output › peer-review

  Open Access
• 2024

  Preclinical evaluation of MC1R targeting theranostic pair [¹⁵⁵Tb]Tb-crown-αMSH and [¹⁶¹Tb]Tb-crown-αMSH

  Wharton, L., McNeil, S. W., Zhang, C., Engudar, G., Van de Voorde, M., Zeisler, J., Koniar, H., Sekar, S., Yuan, Z., Schaffer, P., Radchenko, V., Ooms, M., Kunz, P., Bénard, F. & Yang, H., Sep 2024, In: Nuclear Medicine and Biology. 136-137, 11 p., 108925.

  Research output › peer-review

  Open Access

• Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development

  Koniar, H., McNeil, S., Wharton, L., Ingham, A., van de Voorde, M., Ooms, M., Sekar, S., Rodriguez-Rodriguez, C., Kunz, P., Radchenko, V., Rahmim, A., Uribe, C., Yang, H. & Schaffer, P., Dec 2024, In: EJNMMI Physics. 11, 1, 18 p., 77.

  Research output › peer-review

  Open Access

• Targeted radiopharmaceuticals: an underexplored strategy for ovarian cancer

  Crabbé, M., Opsomer, T., Vermeulen, K., Ooms, M. & Segers, C., 2024, In: Theranostics. 14, 16, p. 6281-6300 20 p.

  Research output › peer-review

  Open Access

• Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside

  Van Laere, C., Koole, M., Deroose, C. M., Van de Voorde, M., Baete, K., Cocolios, T. E., Duchemin, C., Ooms, M. & Cleeren, F., 17 Feb 2024, In: Theranostics. 14, 4, p. 1720-1743 24 p.

  Research output › peer-review

  Open Access
• 2023

  Comparative Study of a Decadentate Acyclic Chelate, HOPO‑O10, and Its Octadentate Analogue, HOPO‑O8, for Radiopharmaceutical Applications

  Carbo-Bague, I., Li, C., McNeil, B. L., Gao, Y., McDonagh, A. W., Van de Voorde, M., Ooms, M., Kunz, P., Yang, H., Radchenko, V., Schreckenbach, G. & Ramogida, C. F., 18 Dec 2023, In: Inorganic Chemistry. 62, 50, p. 20549-20566 18 p., 2c03671.

  Research output › peer-review

  Open Access

• Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist

  Ahenkorah, S., Cawthorne, C., Murce, E., Deroose, C., Cardinaels, T., Seimbille, Y., Bomans, G., Ooms, M. & Cleeren, F., 1 Mar 2023, In: Nuclear Medicine and Biology. 118-119, 10 p., 108338.

  Research output › peer-review

  Open Access

• Preclinical evaluation of [155/161Tb] Tb-Crown-TATE - a novel SPECT imaging theranostic agent targeting neuroendocrine tumours

  Wharton, L., McNeil, S. W., Merkens, H., Yuan, Z., Van de Voorde, M., Engudar, G., Ingham, A., Koniar, H., Rodriguez-Rodriguez, C., Radchenko, V., Ooms, M., Kunz, P., Bénard, F., Schaffer, P. & Yang, H., Apr 2023, In: Molecules. 28, 7, 16 p., 3155.

  Research output › peer-review

  Open Access
• 2022

  3p-C-NETA: A versatile and effective chelator for development of Al¹⁸F-labeled and therapeutic radiopharmaceuticals

  Ahenkorah, S., Murce, E., Cawthorne, C., Ketchemen, J. P., Deroose, C. M., Cardinaels, T., Seimbille, Y., Fonge, H., Gsell, W., Bormans, G., Ooms, M. & Cleeren, F., 2022, In: Theranostics. 12, 13, p. 5971-5985 15 p.

  Research output › peer-review

  Open Access
  7 Scopus citations

• A simple and automated method for 161Tb purification and ICP‑MS analysis of 161Tb

  McNeil, S. W., Van de Voorde, M., Zhang, C., Ooms, M., Bénard, F., Radchenko, V. & Yang, H., 2 Dec 2022, In: EJNMMI Radiopharmacy and Chemistry. 7, 17 p., 31.

  Research output › peer-review

  Open Access

• Bifunctional chelators for radiorhenium: past, present and future outlook

  Melis, D., Burgoyne, A., Ooms, M. & Gasser, G., 14 Jan 2022, In: RSC Medicinal Chemistry. 13, 3, p. 217-245 29 p.

  Research output › peer-review

  Open Access

• Exploring the potential of high-molar activity Samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE

  Vermeulen, K., Van de Voorde, M., Segers, C., Coolkens, A., Rodriguez Perez, S., Duchemin, C., Crabbé, M., Opsomer, T., Saldarriaga Vargas, C., Reinhard, H., Lambert, L., Bernerd, C., Burgoyne, A., Cocolios, T. E., Stora, T. & Ooms, M., 18 Nov 2022, In: Pharmaceutics. 14, p. 1-15 15 p., 2566.

  Research output › peer-review

  Open Access

• Gamma counting protocols for the accurate quantification of 225Ac and 213Bi without the need for a secular equilibrium between parent and gamma‑emitting daughter

  Castillo, D., De Saint-Hubert, M., Ahenkorah, S., Saldarriaga Vargas, C., Ooms, M., Struelens, L. & Koole, M., 23 Oct 2022, In: EJNMMI Radiopharmacy and Chemistry. 7, 28, 17 p., 28.

  Research output › peer-review

  Open Access
• 2021

  Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy

  Van de Voorde, M., Duchemin, C., Reinhard, H., Lambert, L., Chevallay, E., Schneider, T., Van Stenis, M., Cocolios, T. E., Cardinaels, T., Ponsard, B., Ooms, M., Stora, T. & Burgoyne, A., 19 Jul 2021, In: Frontiers in Medicine. 8, p. 1-9 9 p., 675221.

  Research output › peer-review

  Open Access

• Radiolabeling of human serum albumin with terbium-161 using mild conditions and evaluation of in vivo Stability

  Cassells, I., Ahenkorah, S., Burgoyne, A., Van de Voorde, M., Deroose, C., Cardinaels, T., Bormans, G., Ooms, M. & Cleeren, F., 18 Aug 2021, In: Frontiers in Medicine. 8, p. 1-12 12 p., 675122.

  Research output › peer-review

  Open Access
• 2020

  Therapeutic Efficacy of 213 Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer

  Dekempeneer, Y., Caveliers, V., Ooms, M., Gysemans, M., Lahoutte, T., Xavier, C., Lecocq, Q., Maes, K., Covens, P., Miller, B. W., Bruchertseifer, F., Morgenstern, A., Cardinaels, T. & D'huyvetter, M., 19 Jul 2020, In: Molecular Pharmaceutics. 17, 9, p. 3553-3566 14 p.

  Research output › peer-review

  Open Access